Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Lung Neoplasms 7Breast Neoplasms 7Pain, Postoperative 6Thyroid Neoplasms 5Colonic Neoplasms 5Brain Neoplasms 5Stomach Neoplasms 4Neoplasms 4Depression 4Colorectal Neoplasms 4Anxiety Disorders 4Prostatic Neoplasms 3Pain 3Agnosia 3Urinary Bladder Neoplasms 2Supratentorial Neoplasms 2Rectal Neoplasms 2Pancreatic Neoplasms 2Meningioma 2Leiomyoma 2Head and Neck Neoplasms 2Emergence Delirium 2Carcinoma, Hepatocellular 2Adenomyosis 2Warts 1Visceral Pain 1Uterine Cervical Neoplasms 1Urologic Neoplasms 1Thyroid Nodule 1Thrombosis 1

Interventions

Standard of Care 1Saline Solution 1Practice Guidelines as Topic 1Palliative Care 1Multiparametric Magnetic Resonance Imaging 1Lidocaine 1Hepatectomy 1Epirubicin 13-fluoro-2-(4-((2-nitro-1H-imidazol-1-yl)methyl)-1H-1,2,3-triazol-1-yl)propan-1-ol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Disease Progression × Saline Solution × Clear all
NCT05560035 2022-09-29

The Effect of Intravenous Lidocaine on THBS2 and Angiogenic Factors Expression in Women Undergoing Cervical Cancer Surgery

General Hospital of Ningxia Medical University

Phase NA Unknown
60 enrolled
Gynecologic

Uterine Cervical Neoplasms, Neoplasm Metastasis, Disease Progression

Data powered by HemOnc (CC BY 4.0) Colophon âš¡